Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2018 Jul 13;43(2):102-106.
doi: 10.1080/01658107.2018.1482358. eCollection 2019 Apr.

Complete recovery of filler-induced visual loss following subcutaneous hyaluronidase injection

Affiliations
Case Reports

Complete recovery of filler-induced visual loss following subcutaneous hyaluronidase injection

Siti Nurhuda Sharudin et al. Neuroophthalmology. .

Abstract

The rise in popularity of hyaluronic acid (HA) dermal filler injection has caused an exceptional increase in the number of cases of reported irreversible blindness. Here, we reported a case of ischemic optic neuropathy and ophthalmoplegia following subcutaneous HA filler injection with complete visual recovery. A 31-year-old Chinese woman presented with sudden onset of right monocular visual impairment associated with diplopia. Patient had received a hyaluronic acid-containing filler injection for nasal dorsum augmentation twelve hours prior to presentation. Visual acuity of the right eye was counting finger. A right relative afferent pupillary defect was demonstrated with ophthalmoplegia. Humphrey visual field test disclosed a right inferior altitudinal field defect with impairment of colour vision. Computed tomography of the orbit revealed mild enlargement of the right medial and inferior recti muscles. Our patient showed a tremendous improvement of vision after a subcutaneous hyaluronidase injection with complete visual recovery within 2 weeks.

Keywords: Hyaluronic acid injection; hyaluronidase; ischemic optic neuropathy; ophthalmoplegia.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Multiple reticulated skin lesions and erythematous discoloration over the glabella, dorsum and tip of the nose.
Figure 2.
Figure 2.
Nine cardinal positions of gaze showed limitation of right extraocular movements on adduction, depression and elevation.
Figure 3.
Figure 3.
Humphrey 24–2 visual field of the right eye showed inferior altitudinal visual field defect.
Figure 4.
Figure 4.
Axial (A) and coronal view (B) of CT orbit showing enlargement of right medial and inferior rectus.

References

    1. Kim DW, Yoon ES, Ji YH, Park SH, Lee BI, Dhong ES.. Vascular complications of hyaluronic acid fillers and the role of hyaluronidase in management. J Plast Reconstr Aeshet Surg. 2011;64:1590–1595. doi:10.1016/j.bjps.2011.07.013. - DOI - PubMed
    1. Carle MV, Roe R, Novack R, Boyer DS. Cosmetic facial fillers and severe vision loss. JAMA Ophthalmol. 2014;132:637–639. doi:10.1001/jamaophthalmol.2014.498. - DOI - PubMed
    1. Kim YK, Jung C, Woo SJ, Park KH. Cerebral angiographic findings of cosmetic facial filler-related ophthalmic and retinal artery occlusion. J Korean Med Sci. 2015;30:1847–1855. doi:10.3346/jkms.2015.30.12.1847. - DOI - PMC - PubMed
    1. Hayreh SS. Posterior ischaemic optic neuropathy: clinical features, pathogenesis, and management. Eye (Lond). 2004;18:1188–1206. doi:10.1038/sj.eye.6701562. - DOI - PubMed
    1. Kim YJ, Kim SS, Song WK, Lee SY, Yoon JS. Ocular ischemia with hypotony after injection of hyaluronic acid gel. Ophthal Plast Reconstr Surg. 2011;27:152–155. doi:10.1097/IOP.0b013e3182082f37. - DOI - PubMed

Publication types

LinkOut - more resources